Skip to Main Navigation
Skip to Page Content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/3035

TDMS Study 05033-01 Pathology Tables



                                     INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)
                                                             QUERCETIN


NTP Experiment-Test: 05033-01                                                                                     Report: PEIRPT03
Study Type: CHRONIC                                                                                               Date: 09/04/94
Route: DOSED FEED                                                                                                 Time: 20:31:54




       Facility:  TSI Mason Research

       Chemical CAS #:  117-39-5

       Lock Date:  None

       Cage Range:  All

       Reasons For Removal:    All

       Removal Date Range:     All

       Treatment Groups:       Include All
































a  Number of animals examined microscopically at site and number of animals with lesion

                                                             Page   1

NTP Experiment-Test: 05033-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                             QUERCETIN                                         Date: 09/04/94  
Route: DOSED FEED                                                                                                 Time: 20:31:54  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   CONTROL      0.1% LF      1.0% MF      4.0% HF                                   
                                                   UF                                                                               
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY                                                                                                                 
  Animals Initially In Study                          70           70           70           70                                     
  Scheduled Sacrifice                                 20           20           20           20                                     
  Early Deaths                                                                                                                      
    Moribund                                          19           18           13           19                                     
    Dead                                               1            4            2            3                                     
  Survivors                                                                                                                         
    Terminal Sacrifice                                29           28           35           27                                     
    Moribund                                                                                  1                                     
    Dead                                               1                                                                            
  Animals Examined Microscopically                    50           50           50           50                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Intestine Large, Cecum                             (50)         (11)         (8)          (48)                                   
      Necrosis, Acute, Coagulative                                                            1 (2%)                                
      Parasite Metazoan                                2 (4%)                                 4 (8%)                                
      Lymphoid Tissue, Hypoplasia                                   1 (9%)                                                          
   Intestine Large, Colon                             (50)         (11)         (7)          (48)                                   
      Parasite Metazoan                                9 (18%)      1 (9%)       2 (29%)      5 (10%)                               
   Intestine Large, Rectum                            (48)         (11)         (7)          (47)                                   
      Parasite Metazoan                                5 (10%)                                2 (4%)                                
   Intestine Small, Duodenum                          (50)         (48)         (50)         (49)                                   
      Autolysis                                                                  1 (2%)                                             
      Epithelium, Pigmentation                                                                1 (2%)                                
   Intestine Small, Ileum                             (49)         (48)         (49)         (49)                                   
      Epithelium, Pigmentation                                                  19 (39%)     32 (65%)                               
      Serosa, Fibrosis                                              1 (2%)                                                          
   Intestine Small, Jejunum                           (50)         (47)         (49)         (49)                                   
      Autolysis                                                     1 (2%)       1 (2%)                                             
      Epithelium, Pigmentation                                                   3 (6%)      20 (41%)                               
   Liver                                              (50)         (50)         (50)         (50)                                   
      Angiectasis                                      1 (2%)       5 (10%)      1 (2%)                                             
      Basophilic Focus                                40 (80%)     38 (76%)     41 (82%)     39 (78%)                               
      Clear Cell Focus                                 4 (8%)       4 (8%)       4 (8%)       2 (4%)                                
      Cyst                                                                                    2 (4%)                                
      Cyst Multilocular                                                          1 (2%)                                             
      Cytoplasmic Alteration                                        4 (8%)                    1 (2%)                                
      Degeneration                                                  1 (2%)       1 (2%)                                             
      Developmental Malformation                       3 (6%)                                 2 (4%)                                
      Eosinophilic Focus                               3 (6%)                                 3 (6%)                                
      Fatty Change                                    14 (28%)     12 (24%)     12 (24%)      7 (14%)                               
      Fibrosis, Focal                                                                         1 (2%)                                
      Granuloma                                                                  1 (2%)                                             
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    2                                                              
NTP Experiment-Test: 05033-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                             QUERCETIN                                         Date: 09/04/94  
Route: DOSED FEED                                                                                                 Time: 20:31:54  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   CONTROL      0.1% LF      1.0% MF      4.0% HF                                   
                                                   UF                                                                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Hematopoietic Cell Proliferation                              1 (2%)                                                          
      Hemorrhage                                                    1 (2%)       1 (2%)                                             
      Hepatodiaphragmatic Nodule                                    3 (6%)       5 (10%)                                            
      Infarct                                                                                 1 (2%)                                
      Inflammation, Acute                                                        1 (2%)                                             
      Inflammation, Chronic                            1 (2%)                    3 (6%)       3 (6%)                                
      Inflammation, Chronic, Granulomatous            12 (24%)     17 (34%)     10 (20%)      8 (16%)                               
      Inflammation, Chronic Active                     2 (4%)       2 (4%)       2 (4%)       7 (14%)                               
      Mixed Cell Focus                                 4 (8%)       7 (14%)      4 (8%)       1 (2%)                                
      Necrosis, Coagulative                            4 (8%)       5 (10%)      5 (10%)      8 (16%)                               
      Pigmentation                                     1 (2%)       1 (2%)       1 (2%)                                             
      Bile Duct, Cyst Multilocular                                                            1 (2%)                                
      Bile Duct, Hyperplasia                          17 (34%)     14 (28%)     17 (34%)     15 (30%)                               
      Centrilobular, Necrosis, Coagulative                                                    1 (2%)                                
      Serosa, Fibrosis                                              1 (2%)                                                          
      Serosa, Hemorrhage                                            1 (2%)                                                          
   Mesentery                                          (2)          (6)          (2)          (1)                                    
      Fibrosis                                                      6 (100%)     1 (50%)                                            
      Inflammation, Chronic                                         3 (50%)                                                         
      Inflammation, Chronic, Granulomatous             1 (50%)      1 (17%)      1 (50%)                                            
      Inflammation, Chronic Active                                  2 (33%)                                                         
      Mineralization                                                1 (17%)      1 (50%)                                            
      Necrosis, Coagulative                            2 (100%)     3 (50%)                                                         
      Pigmentation                                                               1 (50%)                                            
   Pancreas                                           (50)         (49)         (50)         (50)                                   
      Atrophy                                         21 (42%)     21 (43%)     21 (42%)     15 (30%)                               
      Cytoplasmic Alteration                                        2 (4%)       4 (8%)       2 (4%)                                
      Ectopic Liver                                                                           1 (2%)                                
      Inflammation, Chronic                           17 (34%)     22 (45%)     22 (44%)     17 (34%)                               
      Pigmentation                                                  1 (2%)                                                          
      Artery, Hyperplasia                                                        1 (2%)                                             
      Artery, Perivascular, Inflammation, Chronic,                                                                                  
           Necrotizing                                              1 (2%)                                                          
      Duct, Dilatation                                              1 (2%)                                                          
   Stomach, Forestomach                               (49)         (50)         (50)         (47)                                   
      Acanthosis                                       3 (6%)       3 (6%)       3 (6%)       7 (15%)                               
      Edema                                            1 (2%)       1 (2%)                    1 (2%)                                
      Erosion                                          1 (2%)                                                                       
      Hyperkeratosis                                   3 (6%)       2 (4%)       1 (2%)       7 (15%)                               
      Hyperplasia, Basal Cell                          4 (8%)       2 (4%)       3 (6%)       5 (11%)                               
      Inflammation, Acute                                           1 (2%)                                                          
      Inflammation, Chronic Active                     3 (6%)       3 (6%)                    2 (4%)                                
      Inflammation, Chronic Active, Necrotizing                                  1 (2%)                                             
      Necrosis, Coagulative                                         1 (2%)                                                          
      Ulcer                                            1 (2%)       1 (2%)                    2 (4%)                                
      Artery, Mineralization                                                     1 (2%)                                             
      Artery, Muscularis, Mineralization                            1 (2%)                                                          
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    3                                                              
NTP Experiment-Test: 05033-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                             QUERCETIN                                         Date: 09/04/94  
Route: DOSED FEED                                                                                                 Time: 20:31:54  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   CONTROL      0.1% LF      1.0% MF      4.0% HF                                   
                                                   UF                                                                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Muscularis, Mineralization                                    1 (2%)       3 (6%)                                             
      Submucosa, Mineralization                                                  1 (2%)                                             
   Stomach, Glandular                                 (50)         (49)         (50)         (50)                                   
      Cyst Epithelial Inclusion                                                               1 (2%)                                
      Edema                                                         1 (2%)                                                          
      Inflammation, Chronic Active                     3 (6%)       1 (2%)                    1 (2%)                                
      Ulcer                                            1 (2%)                                                                       
      Artery, Mineralization                                        3 (6%)       1 (2%)                                             
      Epithelium, Pigmentation                                                   8 (16%)     38 (76%)                               
      Mucosa, Dilatation                               6 (12%)                   5 (10%)      4 (8%)                                
      Muscularis, Developmental Malformation           1 (2%)                                                                       
      Muscularis, Mineralization                       1 (2%)       2 (4%)       6 (12%)      4 (8%)                                
   Tongue                                             (29)         (43)         (43)         (39)                                   
      Hemorrhage                                                    2 (5%)       1 (2%)                                             
      Inflammation, Chronic                            7 (24%)      7 (16%)     12 (28%)      6 (15%)                               
      Arteriole, Necrosis, Fibrinoid                                2 (5%)       1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Heart                                              (50)         (13)         (7)          (50)                                   
      Cardiomyopathy                                  47 (94%)      9 (69%)      3 (43%)     47 (94%)                               
      Atrium Left, Thrombosis                                                                 1 (2%)                                
      Coronary Artery, Inflammation, Chronic Active                                           1 (2%)                                
      Coronary Artery, Inflammation, Chronic                                                                                        
          Active, Necrotizing                          1 (2%)                                                                       
      Coronary Artery, Necrosis, Fibrinoid                                                    1 (2%)                                
      Epicardium, Fibrosis                                                                    1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Gland, Cortex                              (50)         (13)         (13)         (50)                                   
      Angiectasis                                     28 (56%)      2 (15%)      2 (15%)     26 (52%)                               
      Atrophy                                                       1 (8%)                                                          
      Congestion                                       1 (2%)                    1 (8%)                                             
      Degeneration, Fatty                              1 (2%)                                                                       
      Hyperplasia                                     16 (32%)                   2 (15%)     15 (30%)                               
      Necrosis, Coagulative                            1 (2%)                                 1 (2%)                                
      Pigmentation                                                  1 (8%)                                                          
      Thrombosis                                       1 (2%)                                                                       
      Vacuolization Cytoplasmic                       28 (56%)      8 (62%)      3 (23%)     24 (48%)                               
   Adrenal Gland, Medulla                             (49)         (13)         (12)         (50)                                   
      Angiectasis                                      5 (10%)                   1 (8%)                                             
      Hyperplasia                                      3 (6%)                    1 (8%)       4 (8%)                                
      Necrosis, Coagulative                            1 (2%)                                                                       
   Islets, Pancreatic                                 (44)         (15)         (8)          (49)                                   
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    4                                                              
NTP Experiment-Test: 05033-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                             QUERCETIN                                         Date: 09/04/94  
Route: DOSED FEED                                                                                                 Time: 20:31:54  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   CONTROL      0.1% LF      1.0% MF      4.0% HF                                   
                                                   UF                                                                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ENDOCRINE SYSTEM - CONT                                                                                                             
      Ectopic Tissue                                   1 (2%)                                                                       
      Hyperplasia                                                   1 (7%)                                                          
   Parathyroid Gland                                  (40)         (39)         (36)         (43)                                   
      Cyst                                             1 (3%)                                                                       
      Hyperplasia                                      1 (3%)                    1 (3%)                                             
   Pituitary Gland                                    (50)         (49)         (50)         (49)                                   
      Angiectasis                                                                             1 (2%)                                
      Hyperplasia                                                                             2 (4%)                                
      Pars Distalis, Angiectasis                      14 (28%)     11 (22%)     12 (24%)      8 (16%)                               
      Pars Distalis, Cyst                             26 (52%)     21 (43%)     23 (46%)     28 (57%)                               
      Pars Distalis, Cyst, Multiple                                              1 (2%)       1 (2%)                                
      Pars Distalis, Hemorrhage                        1 (2%)                                                                       
      Pars Distalis, Hyperplasia                      18 (36%)     23 (47%)     18 (36%)     13 (27%)                               
      Pars Distalis, Infiltration Cellular,                                                                                         
          Histiocyte                                                             1 (2%)                                             
      Pars Distalis, Pigmentation                      1 (2%)       3 (6%)       3 (6%)                                             
      Pars Intermedia, Angiectasis                     5 (10%)      6 (12%)      4 (8%)       6 (12%)                               
      Pars Intermedia, Cyst                                         2 (4%)       7 (14%)      6 (12%)                               
      Pars Intermedia, Pigmentation                                              1 (2%)                                             
      Pars Nervosa, Angiectasis                        1 (2%)       1 (2%)                                                          
      Pars Nervosa, Cyst                                                         1 (2%)                                             
   Thyroid Gland                                      (50)         (43)         (47)         (50)                                   
      Ultimobranchial Cyst                             1 (2%)                                 3 (6%)                                
      C-Cell, Hyperplasia                             38 (76%)     37 (86%)     40 (85%)     37 (74%)                               
      Follicle, Cyst                                   2 (4%)                                 4 (8%)                                
      Follicular Cell, Hyperplasia                                  1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Clitoral Gland                                     (14)         (20)         (14)         (12)                                   
      Abscess                                          1 (7%)       2 (10%)                   1 (8%)                                
      Cyst                                             3 (21%)      2 (10%)      1 (7%)                                             
      Hyperplasia                                      2 (14%)      1 (5%)                                                          
      Inflammation, Acute                                           1 (5%)       1 (7%)                                             
      Inflammation, Chronic                            6 (43%)     10 (50%)      4 (29%)      4 (33%)                               
      Inflammation, Chronic Active                     3 (21%)      2 (10%)      3 (21%)      1 (8%)                                
   Ovary                                              (50)         (17)         (15)         (48)                                   
      Congestion                                                                 1 (7%)                                             
      Cyst                                             3 (6%)                                 2 (4%)                                
      Periovarian Tissue, Cyst                         5 (10%)      3 (18%)      9 (60%)      5 (10%)                               
   Uterus                                             (50)         (50)         (50)         (50)                                   
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    5                                                              
NTP Experiment-Test: 05033-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                             QUERCETIN                                         Date: 09/04/94  
Route: DOSED FEED                                                                                                 Time: 20:31:54  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   CONTROL      0.1% LF      1.0% MF      4.0% HF                                   
                                                   UF                                                                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
GENITAL SYSTEM - CONT                                                                                                               
      Cyst                                                                       3 (6%)                                             
      Hydrometra                                      11 (22%)      9 (18%)      5 (10%)     14 (28%)                               
      Inflammation, Acute                                                                     1 (2%)                                
      Inflammation, Chronic                                         2 (4%)                                                          
      Inflammation, Chronic Active                                               1 (2%)       1 (2%)                                
      Metaplasia, Squamous                                                                    1 (2%)                                
      Pigmentation                                                  1 (2%)                                                          
      Cervix, Cyst                                                  1 (2%)                                                          
      Cervix, Inflammation, Chronic                                 1 (2%)                                                          
      Endometrium, Hyperplasia                         6 (12%)      7 (14%)      8 (16%)      7 (14%)                               
      Lumen, Exudate                                   2 (4%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Lymph Node                                         (48)         (25)         (17)         (49)                                   
      Deep Cervical, Hyperplasia, Plasma Cell          1 (2%)                                                                       
      Lumbar, Infiltration Cellular, Histiocyte                                               1 (2%)                                
      Lumbar, Pigmentation                                                                    1 (2%)                                
      Mediastinal, Depletion Lymphoid                                                         1 (2%)                                
      Mediastinal, Hemorrhage                          8 (17%)      3 (12%)      3 (18%)      7 (14%)                               
      Mediastinal, Infiltration Cellular,                                                                                           
          Histiocyte                                                                          1 (2%)                                
      Mediastinal, Necrosis, Coagulative                                                      1 (2%)                                
      Mediastinal, Pigmentation                        2 (4%)       1 (4%)       1 (6%)       2 (4%)                                
      Pancreatic, Ectasia                                                        1 (6%)       1 (2%)                                
      Pancreatic, Hemorrhage                           1 (2%)                                 2 (4%)                                
      Pancreatic, Infiltration Cellular, Histiocyte                              2 (12%)      2 (4%)                                
      Pancreatic, Pigmentation                                                   2 (12%)      3 (6%)                                
      Renal, Ectasia                                                2 (8%)                                                          
      Renal, Hemorrhage                                2 (4%)       1 (4%)       2 (12%)      3 (6%)                                
      Renal, Infiltration Cellular                     1 (2%)                                                                       
      Renal, Infiltration Cellular, Histiocyte         1 (2%)       3 (12%)      2 (12%)      4 (8%)                                
      Renal, Pigmentation                              1 (2%)       4 (16%)      2 (12%)      3 (6%)                                
   Lymph Node, Mandibular                             (46)         (19)         (10)         (46)                                   
      Congestion                                                    1 (5%)                                                          
      Ectasia                                         11 (24%)      5 (26%)                   6 (13%)                               
      Hemorrhage                                      22 (48%)      6 (32%)      3 (30%)     17 (37%)                               
      Hyperplasia, Plasma Cell                         2 (4%)                                                                       
      Infiltration Cellular, Histiocyte                             2 (11%)      1 (10%)      2 (4%)                                
      Necrosis, Coagulative                                                      1 (10%)                                            
      Pigmentation                                     1 (2%)       2 (11%)                   2 (4%)                                
   Lymph Node, Mesenteric                             (9)          (14)         (12)         (9)                                    
      Angiectasis                                                                1 (8%)                                             
      Ectasia                                                                    1 (8%)       1 (11%)                               
      Hemorrhage                                       1 (11%)                   2 (17%)                                            
      Infiltration Cellular, Histiocyte                8 (89%)     14 (100%)    10 (83%)      7 (78%)                               
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    6                                                              
NTP Experiment-Test: 05033-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                             QUERCETIN                                         Date: 09/04/94  
Route: DOSED FEED                                                                                                 Time: 20:31:54  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   CONTROL      0.1% LF      1.0% MF      4.0% HF                                   
                                                   UF                                                                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
HEMATOPOIETIC SYSTEM - CONT                                                                                                         
      Necrosis, Coagulative                                                                   1 (11%)                               
      Pigmentation                                     8 (89%)     14 (100%)     8 (67%)      7 (78%)                               
      Thrombosis                                                                 1 (8%)                                             
   Spleen                                             (50)         (23)         (20)         (50)                                   
      Depletion Lymphoid                               5 (10%)      5 (22%)      4 (20%)      9 (18%)                               
      Fibrosis                                                      1 (4%)                                                          
      Hematopoietic Cell Proliferation                              2 (9%)       1 (5%)       1 (2%)                                
      Hyperplasia, Lymphoid                                                      3 (15%)                                            
      Inflammation, Chronic, Granulomatous                          2 (9%)       3 (15%)      1 (2%)                                
      Necrosis                                                                                1 (2%)                                
      Pigmentation                                     1 (2%)                                                                       
      Thrombosis                                       1 (2%)       1 (4%)                                                          
      Capsule, Hyperplasia                             1 (2%)                                                                       
   Thymus                                             (8)          (10)         (7)          (9)                                    
      Depletion Lymphoid                               5 (63%)      7 (70%)      1 (14%)      7 (78%)                               
      Hemorrhage                                                    1 (10%)      1 (14%)                                            
      Necrosis, Coagulative                                                                   1 (11%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (36)         (36)         (24)         (22)                                   
      Galactocele                                                   1 (3%)       1 (4%)       1 (5%)                                
      Hyperplasia                                     13 (36%)     20 (56%)     13 (54%)     13 (59%)                               
      Hyperplasia, Cystic                              1 (3%)                                                                       
   Skin                                               (11)         (15)         (8)          (11)                                   
      Inflammation, Acute, Necrotizing                                           1 (13%)                                            
      Inflammation, Chronic                                         1 (7%)                                                          
      Subcutaneous Tissue, Edema                                                              1 (9%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (50)         (15)         (8)          (50)                                   
      Hemorrhage                                                                              2 (4%)                                
      Hydrocephalus                                    2 (4%)       1 (7%)       1 (13%)      1 (2%)                                
      Meninges, Hemorrhage                                          2 (13%)                                                         
   Spinal Cord                                        (1)          (2)                       (2)                                    
      Hemorrhage                                                    1 (50%)                   1 (50%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    7                                                              
NTP Experiment-Test: 05033-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                             QUERCETIN                                         Date: 09/04/94  
Route: DOSED FEED                                                                                                 Time: 20:31:54  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   CONTROL      0.1% LF      1.0% MF      4.0% HF                                   
                                                   UF                                                                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (50)         (20)         (20)         (50)                                   
      Crystals                                         1 (2%)                                                                       
      Foreign Body                                                               1 (5%)                                             
      Hemorrhage                                       4 (8%)       3 (15%)      2 (10%)      4 (8%)                                
      Infiltration Cellular, Histiocyte               14 (28%)      5 (25%)      3 (15%)     18 (36%)                               
      Inflammation, Acute                                                                     1 (2%)                                
      Inflammation, Chronic                            1 (2%)                                 1 (2%)                                
      Inflammation, Chronic Active                                               1 (5%)       1 (2%)                                
      Leukocytosis                                                               1 (5%)                                             
      Metaplasia, Osseous                              1 (2%)                                                                       
      Pigmentation                                                                            1 (2%)                                
      Alveolar Epithelium, Hyperplasia                 2 (4%)       1 (5%)       2 (10%)      1 (2%)                                
      Artery, Mineralization                          24 (48%)      3 (15%)      6 (30%)     14 (28%)                               
   Nose                                               (7)          (12)         (7)          (10)                                   
      Congestion                                                    1 (8%)                                                          
      Capillary, Submucosa, Thrombosis                                                        1 (10%)                               
      Glands, Inflammation, Acute                                                1 (14%)      1 (10%)                               
      Lumen, Inflammation, Acute                                    1 (8%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Eye                                                (6)          (8)          (6)          (5)                                    
      Cataract                                         5 (83%)      2 (25%)      3 (50%)      1 (20%)                               
      Synechia                                         1 (17%)      3 (38%)      3 (50%)                                            
      Cornea, Fibrosis                                              2 (25%)                                                         
      Retina, Degeneration                             5 (83%)      6 (75%)      4 (67%)      2 (40%)                               
      Sclera, Metaplasia, Osseous                                                             1 (20%)                               
      Sclera, Mineralization                           1 (17%)                                                                      
   Harderian Gland                                                 (4)          (2)          (2)                                    
      Hemorrhage                                                    1 (25%)      1 (50%)                                            
      Inflammation, Acute                                           1 (25%)                                                         
      Inflammation, Chronic                                         3 (75%)      1 (50%)      1 (50%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (49)         (49)         (50)         (50)                                   
      Autolysis                                                     1 (2%)       1 (2%)                                             
      Congestion                                                    1 (2%)                    1 (2%)                                
      Inflammation, Chronic                                         1 (2%)       1 (2%)                                             
      Nephropathy                                     48 (98%)     48 (98%)     50 (100%)    48 (96%)                               
      Artery, Fibrosis                                              1 (2%)                                                          
      Artery, Thrombosis                                                         1 (2%)                                             
      Collecting Tubule, Mineralization                1 (2%)                                                                       
      Papilla, Necrosis, Coagulative                                             1 (2%)                                             
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    8                                                              
NTP Experiment-Test: 05033-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                             QUERCETIN                                         Date: 09/04/94  
Route: DOSED FEED                                                                                                 Time: 20:31:54  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   CONTROL      0.1% LF      1.0% MF      4.0% HF                                   
                                                   UF                                                                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
URINARY SYSTEM - CONT                                                                                                               
      Proximal Convoluted Renal Tubule,                                                                                             
          Degeneration, Hyaline                                     1 (2%)                                                          
      Proximal Convoluted Renal Tubule,                                                                                             
          Inflammation, Acute                                       4 (8%)                                                          
      Proximal Convoluted Renal Tubule,                                                                                             
          Pigmentation                                              1 (2%)       1 (2%)                                             
      Renal Tubule, Hyperplasia                        1 (2%)       1 (2%)       3 (6%)       1 (2%)                                
      Renal Tubule, Hyperplasia, Cystic                                          1 (2%)                                             
      Transitional Epithelium, Hyperplasia             7 (14%)      9 (18%)      5 (10%)      4 (8%)                                
   Urinary Bladder                                    (50)         (49)         (50)         (50)                                   
      Hemorrhage                                                                              1 (2%)                                
      Inflammation, Acute                                                                     1 (2%)                                
      Inflammation, Chronic                                         4 (8%)                                                          
      Subserosa, Mineralization                        1 (2%)                                                                       
      Transitional Epithelium, Hyperplasia                                                    2 (4%)                                
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    9                                                              
NTP Experiment-Test: 05033-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                             QUERCETIN                                         Date: 09/04/94  
Route: DOSED FEED                                                                                                 Time: 20:31:54  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     CONTROL      0.1% LM      1.0% MM      4.0% HM                                   
                                                   UM                                                                               
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY                                                                                                                 
  Animals Initially In Study                          70           70           70           70                                     
  Scheduled Sacrifice                                 20           20           20           20                                     
  Early Deaths                                                                                                                      
    Moribund                                          21           15           22           21                                     
    Dead                                               3            7            3            6                                     
  Survivors                                                                                                                         
    Moribund                                                                     1            1                                     
    Terminal Sacrifice                                25           27           22           19                                     
    Dead                                               1            1            2            3                                     
  Animals Examined Microscopically                    50           50           50           50                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Intestine Large, Cecum                             (49)         (11)         (13)         (46)                                   
      Parasite Metazoan                                4 (8%)       1 (9%)                    4 (9%)                                
   Intestine Large, Colon                             (49)         (12)         (11)         (47)                                   
      Parasite Metazoan                                9 (18%)      2 (17%)      1 (9%)       3 (6%)                                
      Epithelium, Pigmentation                                                                1 (2%)                                
   Intestine Large, Rectum                            (49)         (11)         (10)         (46)                                   
      Parasite Metazoan                                3 (6%)                                 4 (9%)                                
   Intestine Small, Duodenum                          (48)         (47)         (48)         (46)                                   
      Epithelium, Pigmentation                                                                3 (7%)                                
   Intestine Small, Ileum                             (47)         (47)         (48)         (45)                                   
      Necrosis, Coagulative                                         1 (2%)                                                          
      Epithelium, Pigmentation                                      1 (2%)      15 (31%)     28 (62%)                               
      Peyer's Patch, Hyperplasia                                                 1 (2%)                                             
   Intestine Small, Jejunum                           (48)         (44)         (43)         (44)                                   
      Autolysis                                                                  1 (2%)                                             
      Epithelium, Pigmentation                                                   2 (5%)      19 (43%)                               
   Liver                                              (50)         (50)         (50)         (50)                                   
      Angiectasis                                                   2 (4%)       2 (4%)       2 (4%)                                
      Basophilic Focus                                16 (32%)     17 (34%)     18 (36%)     20 (40%)                               
      Clear Cell Focus                                 7 (14%)     10 (20%)      5 (10%)      8 (16%)                               
      Congestion                                       1 (2%)                                                                       
      Cyst                                                                                    1 (2%)                                
      Cyst Multilocular                                                                       1 (2%)                                
      Cytoplasmic Alteration                           2 (4%)       3 (6%)       1 (2%)                                             
      Degeneration                                     4 (8%)       2 (4%)       1 (2%)                                             
      Degeneration, Cystic                             6 (12%)      5 (10%)      9 (18%)      2 (4%)                                
      Eosinophilic Focus                               9 (18%)      5 (10%)      7 (14%)      3 (6%)                                
      Fatty Change                                     5 (10%)     12 (24%)      5 (10%)      8 (16%)                               
      Fibrosis                                         2 (4%)                                                                       
      Hemorrhage                                       1 (2%)       4 (8%)       3 (6%)       3 (6%)                                
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   10                                                              
NTP Experiment-Test: 05033-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                             QUERCETIN                                         Date: 09/04/94  
Route: DOSED FEED                                                                                                 Time: 20:31:54  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     CONTROL      0.1% LM      1.0% MM      4.0% HM                                   
                                                   UM                                                                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Hepatodiaphragmatic Nodule                       2 (4%)       1 (2%)                    1 (2%)                                
      Hyperplasia, Focal                               1 (2%)       2 (4%)                                                          
      Inflammation, Chronic                           24 (48%)     30 (60%)     26 (52%)     23 (46%)                               
      Mixed Cell Focus                                 3 (6%)       4 (8%)       4 (8%)       3 (6%)                                
      Mixed Cell Focus, Multiple                                                 1 (2%)                                             
      Necrosis, Coagulative                            7 (14%)      8 (16%)      9 (18%)      7 (14%)                               
      Thrombosis                                                    1 (2%)       1 (2%)       1 (2%)                                
      Bile Duct, Hyperplasia                          46 (92%)     48 (96%)     47 (94%)     30 (60%)                               
      Centrilobular, Necrosis, Coagulative                          1 (2%)       1 (2%)       2 (4%)                                
   Mesentery                                          (7)          (6)          (5)          (5)                                    
      Fibrosis                                                      1 (17%)      1 (20%)                                            
      Inflammation, Chronic                            2 (29%)                                1 (20%)                               
      Inflammation, Chronic, Granulomatous                                                    2 (40%)                               
      Mineralization                                                             1 (20%)      1 (20%)                               
      Necrosis, Coagulative                            1 (14%)      2 (33%)      1 (20%)      1 (20%)                               
      Pigmentation                                     1 (14%)                   1 (20%)                                            
   Pancreas                                           (50)         (50)         (50)         (47)                                   
      Atrophy                                         23 (46%)     26 (52%)     23 (46%)     24 (51%)                               
      Cyst                                                                       1 (2%)       1 (2%)                                
      Cytoplasmic Alteration                                        2 (4%)                    3 (6%)                                
      Ectopic Liver                                                 1 (2%)                    1 (2%)                                
      Fibrosis                                                                   2 (4%)                                             
      Hyperplasia                                                   3 (6%)       3 (6%)       1 (2%)                                
      Inflammation, Chronic                           32 (64%)     28 (56%)     30 (60%)     34 (72%)                               
      Necrosis, Coagulative                                                      1 (2%)                                             
      Pigmentation                                     1 (2%)                    2 (4%)                                             
      Thrombosis                                                                 1 (2%)                                             
      Artery, Fibrosis                                              3 (6%)                                                          
      Artery, Inflammation, Chronic Active,                                                                                         
          Necrotizing                                               1 (2%)       2 (4%)                                             
      Artery, Mineralization                                                                  1 (2%)                                
      Duct, Dilatation                                 1 (2%)       1 (2%)                                                          
      Perivascular, Inflammation, Chronic                           3 (6%)                                                          
      Serosa, Hyperplasia                                                        1 (2%)                                             
   Salivary Glands                                    (16)         (14)         (12)         (10)                                   
      Parotid Gland, Vacuolization Cytoplasmic                                   1 (8%)                                             
   Stomach, Forestomach                               (49)         (49)         (49)         (46)                                   
      Acanthosis                                                    6 (12%)      2 (4%)       5 (11%)                               
      Edema                                                                                   1 (2%)                                
      Fibrosis                                                                                1 (2%)                                
      Hyperkeratosis                                                3 (6%)       2 (4%)       5 (11%)                               
      Hyperplasia, Basal Cell                          3 (6%)       9 (18%)      8 (16%)      2 (4%)                                
      Hyperplasia, Pseudoepitheliomatous                                                      1 (2%)                                
      Inflammation, Acute                                           1 (2%)                                                          
      Inflammation, Chronic Active                     1 (2%)       1 (2%)                    3 (7%)                                
      Mineralization                                                             3 (6%)       2 (4%)                                
      Ulcer                                                         1 (2%)       1 (2%)                                             
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   11                                                              
NTP Experiment-Test: 05033-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                             QUERCETIN                                         Date: 09/04/94  
Route: DOSED FEED                                                                                                 Time: 20:31:54  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     CONTROL      0.1% LM      1.0% MM      4.0% HM                                   
                                                   UM                                                                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Muscularis, Pigmentation                                                   1 (2%)                                             
   Stomach, Glandular                                 (50)         (50)         (49)         (48)                                   
      Edema                                                                                   1 (2%)                                
      Hemorrhage                                                                 1 (2%)                                             
      Inflammation, Chronic Active                     1 (2%)       1 (2%)                    1 (2%)                                
      Necrosis, Coagulative                                         1 (2%)       1 (2%)                                             
      Epithelium, Pigmentation                                                   3 (6%)      34 (71%)                               
      Mucosa, Mineralization                                                     3 (6%)       7 (15%)                               
      Muscularis, Mineralization                       1 (2%)                    1 (2%)                                             
      Submucosa, Fibrosis                              1 (2%)                                                                       
   Tongue                                             (45)         (48)         (47)         (44)                                   
      Hemorrhage                                                    1 (2%)                                                          
      Inflammation, Acute, Necrotizing                                                        1 (2%)                                
      Metaplasia, Osseous                              1 (2%)                                                                       
      Artery, Mineralization                                                     1 (2%)       4 (9%)                                
      Artery, Endothelium, Hyperplasia                                                        1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Blood Vessel                                       (1)                       (1)          (2)                                    
      Aorta, Mineralization                            1 (100%)                  1 (100%)     2 (100%)                              
   Heart                                              (50)         (18)         (18)         (50)                                   
      Cardiomyopathy                                  48 (96%)     14 (78%)     15 (83%)     49 (98%)                               
      Cytomegaly                                                    1 (6%)                                                          
      Edema                                                                                   1 (2%)                                
      Inflammation, Chronic                                                                   1 (2%)                                
      Metaplasia, Osseous                                                        2 (11%)      1 (2%)                                
      Mineralization                                                                          2 (4%)                                
      Thrombosis                                       6 (12%)      1 (6%)       5 (28%)      1 (2%)                                
      Artery, Mineralization                                                                  3 (6%)                                
      Coronary Artery, Inflammation, Chronic Active    1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Gland, Cortex                              (50)         (18)         (21)         (49)                                   
      Angiectasis                                      6 (12%)      1 (6%)       2 (10%)      8 (16%)                               
      Atrophy                                          1 (2%)                                                                       
      Congestion                                       1 (2%)       3 (17%)                   2 (4%)                                
      Hematopoietic Cell Proliferation                 1 (2%)                                                                       
      Hemorrhage                                                                 1 (5%)                                             
      Hyperplasia                                     10 (20%)      2 (11%)      1 (5%)      14 (29%)                               
      Necrosis, Coagulative                                         2 (11%)      1 (5%)       1 (2%)                                
      Vacuolization Cytoplasmic                       26 (52%)     12 (67%)      8 (38%)     27 (55%)                               
   Adrenal Gland, Medulla                             (50)         (18)         (21)         (49)                                   
      Angiectasis                                      2 (4%)                                 1 (2%)                                
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   12                                                              
NTP Experiment-Test: 05033-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                             QUERCETIN                                         Date: 09/04/94  
Route: DOSED FEED                                                                                                 Time: 20:31:54  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     CONTROL      0.1% LM      1.0% MM      4.0% HM                                   
                                                   UM                                                                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ENDOCRINE SYSTEM - CONT                                                                                                             
      Atrophy                                          1 (2%)                                                                       
      Congestion                                                                              2 (4%)                                
      Hyperplasia                                     22 (44%)      2 (11%)      3 (14%)     21 (43%)                               
      Necrosis, Coagulative                            1 (2%)                                 1 (2%)                                
   Islets, Pancreatic                                 (47)         (15)         (13)         (41)                                   
      Hyperplasia                                      1 (2%)       1 (7%)                    1 (2%)                                
   Parathyroid Gland                                  (43)         (45)         (43)         (43)                                   
      Hyperplasia                                      1 (2%)       6 (13%)      6 (14%)     17 (40%)                               
   Pituitary Gland                                    (46)         (49)         (50)         (48)                                   
      Autolysis                                                     1 (2%)                    3 (6%)                                
      Hemorrhage                                                                              1 (2%)                                
      Pars Distalis, Angiectasis                       2 (4%)       1 (2%)       1 (2%)       1 (2%)                                
      Pars Distalis, Autolysis                                      1 (2%)       2 (4%)                                             
      Pars Distalis, Congestion                                                  1 (2%)                                             
      Pars Distalis, Cyst                              7 (15%)      6 (12%)      4 (8%)       7 (15%)                               
      Pars Distalis, Hyperplasia                      18 (39%)     24 (49%)     17 (34%)     20 (42%)                               
      Pars Distalis, Necrosis                                       1 (2%)                                                          
      Pars Distalis, Pigmentation                                   5 (10%)      1 (2%)                                             
      Pars Intermedia, Angiectasis                                  2 (4%)       3 (6%)                                             
      Pars Intermedia, Crystals                                                  1 (2%)                                             
      Pars Intermedia, Cyst                            6 (13%)     10 (20%)     14 (28%)      7 (15%)                               
      Pars Intermedia, Ectopic Tissue                                            1 (2%)                                             
      Pars Intermedia, Hyperplasia                                               1 (2%)                                             
      Pars Nervosa, Cyst                                                                      1 (2%)                                
      Pars Nervosa, Ectopic Tissue                                               1 (2%)                                             
      Pars Nervosa, Hyperplasia                                                  1 (2%)                                             
      Rathke's Cleft, Cyst                                                       1 (2%)                                             
   Thyroid Gland                                      (50)         (17)         (22)         (49)                                   
      Congestion                                                    1 (6%)                                                          
      Inflammation, Acute                              1 (2%)                                                                       
      Ultimobranchial Cyst                             2 (4%)                                                                       
      C-Cell, Hyperplasia                             17 (34%)      3 (18%)      6 (27%)     16 (33%)                               
      Follicle, Pigmentation                           1 (2%)                    1 (5%)       6 (12%)                               
      Follicular Cell, Cyst                                                                   3 (6%)                                
      Follicular Cell, Hyperplasia                     2 (4%)                    1 (5%)       1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   13                                                              
NTP Experiment-Test: 05033-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                             QUERCETIN                                         Date: 09/04/94  
Route: DOSED FEED                                                                                                 Time: 20:31:54  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     CONTROL      0.1% LM      1.0% MM      4.0% HM                                   
                                                   UM                                                                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Coagulating Gland                                  (2)          (1)          (2)                                                 
      Adventitia, Inflammation, Chronic Active         1 (50%)                                                                      
   Preputial Gland                                    (13)         (22)         (19)         (15)                                   
      Abscess                                                       5 (23%)      2 (11%)                                            
      Cyst                                             1 (8%)                                                                       
      Hyperplasia                                                                             1 (7%)                                
      Inflammation, Chronic                           12 (92%)     19 (86%)     13 (68%)     13 (87%)                               
      Duct, Dilatation                                              1 (5%)                                                          
   Prostate                                           (49)         (14)         (12)         (48)                                   
      Fibrosis                                                                                1 (2%)                                
      Hemorrhage                                                    1 (7%)                                                          
      Inflammation, Acute                                           1 (7%)                                                          
      Inflammation, Chronic                                                                   1 (2%)                                
      Inflammation, Chronic Active                    25 (51%)      9 (64%)     10 (83%)     30 (63%)                               
      Epithelium, Hyperplasia                          2 (4%)                                 2 (4%)                                
   Seminal Vesicle                                    (50)         (22)         (23)         (49)                                   
      Atrophy                                         36 (72%)      9 (41%)      9 (39%)     39 (80%)                               
   Testes                                             (50)         (46)         (48)         (50)                                   
      Infarct                                                       1 (2%)                                                          
      Necrosis, Coagulative                            1 (2%)                                 1 (2%)                                
      Interstitial Cell, Hyperplasia                  34 (68%)     35 (76%)     41 (85%)     44 (88%)                               
      Seminiferous Tubule, Atrophy                    44 (88%)     44 (96%)     43 (90%)     46 (92%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (11)         (12)         (12)         (9)                                    
      Fibrosis                                                                                1 (11%)                               
   Lymph Node                                         (49)         (29)         (26)         (50)                                   
      Angiectasis                                                   1 (3%)                                                          
      Artery, Pancreatic, Thrombosis                                             1 (4%)                                             
      Inguinal, Ectasia                                             1 (3%)                                                          
      Lumbar, Ectasia                                  1 (2%)       3 (10%)                                                         
      Lumbar, Hemorrhage                               1 (2%)       1 (3%)       1 (4%)                                             
      Lumbar, Hyperplasia, Plasma Cell                                           1 (4%)                                             
      Lumbar, Infiltration Cellular, Histiocyte                     1 (3%)                                                          
      Lumbar, Inflammation, Acute                                   1 (3%)                                                          
      Lumbar, Pigmentation                                          1 (3%)                                                          
      Mediastinal, Depletion Lymphoid                                                         1 (2%)                                
      Mediastinal, Ectasia                                          2 (7%)       3 (12%)                                            
      Mediastinal, Hemorrhage                          6 (12%)      4 (14%)      3 (12%)      6 (12%)                               
      Mediastinal, Infiltration Cellular,                                                                                           
          Histiocyte                                                             1 (4%)                                             
      Mediastinal, Pigmentation                        1 (2%)       5 (17%)      2 (8%)       1 (2%)                                
      Pancreatic, Ectasia                              1 (2%)                                                                       
      Pancreatic, Hemorrhage                           3 (6%)       2 (7%)       2 (8%)       2 (4%)                                
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   14                                                              
NTP Experiment-Test: 05033-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                             QUERCETIN                                         Date: 09/04/94  
Route: DOSED FEED                                                                                                 Time: 20:31:54  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     CONTROL      0.1% LM      1.0% MM      4.0% HM                                   
                                                   UM                                                                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
HEMATOPOIETIC SYSTEM - CONT                                                                                                         
      Pancreatic, Hyperplasia, Plasma Cell             1 (2%)                                                                       
      Pancreatic, Infiltration Cellular, Histiocyte    3 (6%)       5 (17%)      2 (8%)                                             
      Pancreatic, Pigmentation                         3 (6%)       2 (7%)       3 (12%)                                            
      Renal, Ectasia                                   1 (2%)       2 (7%)       2 (8%)       1 (2%)                                
      Renal, Fibrosis                                               1 (3%)                                                          
      Renal, Hemorrhage                                5 (10%)      4 (14%)      5 (19%)      5 (10%)                               
      Renal, Hyperplasia, Lymphoid                                               1 (4%)                                             
      Renal, Hyperplasia, Plasma Cell                  1 (2%)                                 1 (2%)                                
      Renal, Infiltration Cellular, Histiocyte                      4 (14%)      2 (8%)       2 (4%)                                
      Renal, Pigmentation                              6 (12%)      6 (21%)      3 (12%)      5 (10%)                               
   Lymph Node, Mandibular                             (46)         (18)         (15)         (47)                                   
      Angiectasis                                      1 (2%)                                                                       
      Congestion                                                    1 (6%)                    1 (2%)                                
      Depletion Lymphoid                                                                      1 (2%)                                
      Ectasia                                          3 (7%)       1 (6%)       3 (20%)     10 (21%)                               
      Hemorrhage                                      12 (26%)      4 (22%)      2 (13%)     12 (26%)                               
      Hyperplasia, Plasma Cell                         3 (7%)                                 1 (2%)                                
      Infiltration Cellular, Histiocyte                                                       3 (6%)                                
      Pigmentation                                                                            2 (4%)                                
   Lymph Node, Mesenteric                             (22)         (14)         (17)         (19)                                   
      Ectasia                                                                    1 (6%)      12 (63%)                               
      Hemorrhage                                       3 (14%)      1 (7%)       4 (24%)      3 (16%)                               
      Hyperplasia, Plasma Cell                         1 (5%)                                                                       
      Infiltration Cellular, Histiocyte               11 (50%)     10 (71%)     14 (82%)      9 (47%)                               
      Pigmentation                                     9 (41%)      9 (64%)     10 (59%)      8 (42%)                               
   Spleen                                             (50)         (25)         (38)         (50)                                   
      Congestion                                       1 (2%)       2 (8%)       1 (3%)                                             
      Depletion Lymphoid                               9 (18%)     14 (56%)     13 (34%)      9 (18%)                               
      Fibrosis                                         6 (12%)      5 (20%)      8 (21%)      1 (2%)                                
      Hematopoietic Cell Proliferation                 1 (2%)       2 (8%)       1 (3%)       3 (6%)                                
      Hyperplasia, Lymphoid                                                      1 (3%)                                             
      Infarct                                          2 (4%)                                                                       
      Necrosis, Coagulative                            1 (2%)                                                                       
      Pigmentation                                     1 (2%)                    1 (3%)                                             
      Thrombosis                                                                 1 (3%)                                             
   Thymus                                             (14)         (11)         (13)         (5)                                    
      Congestion                                                                 1 (8%)                                             
      Depletion Lymphoid                               7 (50%)      5 (45%)      5 (38%)      5 (100%)                              
      Hemorrhage                                       1 (7%)       1 (9%)       1 (8%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (13)         (10)         (14)         (9)                                    
      Abscess                                                       1 (10%)                                                         
      Galactocele                                      1 (8%)       1 (10%)                   1 (11%)                               
      Hyperplasia                                      7 (54%)      9 (90%)      9 (64%)      6 (67%)                               
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   15                                                              
NTP Experiment-Test: 05033-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                             QUERCETIN                                         Date: 09/04/94  
Route: DOSED FEED                                                                                                 Time: 20:31:54  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     CONTROL      0.1% LM      1.0% MM      4.0% HM                                   
                                                   UM                                                                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
INTEGUMENTARY SYSTEM - CONT                                                                                                         
      Pigmentation                                                  3 (30%)      3 (21%)      1 (11%)                               
   Skin                                               (20)         (18)         (19)         (18)                                   
      Acanthosis                                       1 (5%)                    1 (5%)       3 (17%)                               
      Cyst Epithelial Inclusion                        2 (10%)      3 (17%)                                                         
      Fibrosis                                                                   1 (5%)                                             
      Hyperkeratosis                                   1 (5%)       1 (6%)       1 (5%)       3 (17%)                               
      Hyperplasia, Basal Cell                                                                 1 (6%)                                
      Inflammation, Acute, Necrotizing                                                        1 (6%)                                
      Subcutaneous Tissue, Abscess                     1 (5%)                                 1 (6%)                                
      Subcutaneous Tissue, Edema                       1 (5%)                                                                       
      Subcutaneous Tissue, Inflammation, Chronic                                                                                    
          Active                                                                 1 (5%)                                             
      Subcutaneous Tissue, Inflammation,                                                                                            
          Granulomatous                                1 (5%)       1 (6%)                    1 (6%)                                
      Subcutaneous Tissue, Necrosis, Coagulative                                              1 (6%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Skeletal Muscle                                    (1)          (2)                                                              
      Hindlimb, Mineralization                                      1 (50%)                                                         
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (50)         (15)         (12)         (50)                                   
      Hemorrhage                                       2 (4%)       2 (13%)                   2 (4%)                                
      Cerebellum, Infarct                              1 (2%)                                                                       
      Cerebrum, Degeneration, Focal                                              1 (8%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (50)         (28)         (31)         (50)                                   
      Congestion                                                    1 (4%)       1 (3%)       1 (2%)                                
      Edema                                                                      2 (6%)       1 (2%)                                
      Hemorrhage                                       4 (8%)       6 (21%)      5 (16%)      1 (2%)                                
      Infiltration Cellular, Histiocyte               31 (62%)     18 (64%)     18 (58%)     43 (86%)                               
      Inflammation, Chronic Active                                               1 (3%)                                             
      Metaplasia, Osseous                                                        1 (3%)       2 (4%)                                
      Necrosis, Coagulative                            1 (2%)                                                                       
      Alveolar Epithelium, Hyperplasia                              4 (14%)      2 (6%)       3 (6%)                                
      Artery, Mineralization                          34 (68%)     13 (46%)     17 (55%)     43 (86%)                               
      Bronchiole, Epithelium, Hyperplasia                                        1 (3%)       1 (2%)                                
   Nose                                               (44)         (48)         (49)         (49)                                   
      Foreign Body                                                  1 (2%)                                                          
      Metaplasia, Squamous                                          1 (2%)       2 (4%)       1 (2%)                                
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   16                                                              
NTP Experiment-Test: 05033-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                             QUERCETIN                                         Date: 09/04/94  
Route: DOSED FEED                                                                                                 Time: 20:31:54  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     CONTROL      0.1% LM      1.0% MM      4.0% HM                                   
                                                   UM                                                                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
RESPIRATORY SYSTEM - CONT                                                                                                           
      Glands, Inflammation, Acute                     11 (25%)     11 (23%)      4 (8%)       5 (10%)                               
      Lumen, Hemorrhage                                             1 (2%)                                                          
      Lumen, Inflammation, Acute                       2 (5%)       3 (6%)       9 (18%)      3 (6%)                                
      Mucosa, Congestion                                                         1 (2%)                                             
      Nasopharyngeal Duct, Inflammation, Acute                      1 (2%)                                                          
      Nasopharyngeal Duct, Inflammation, Chronic       1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Eye                                                (2)          (9)          (6)          (3)                                    
      Atrophy                                                                                 1 (33%)                               
      Synechia                                                                                1 (33%)                               
      Artery, Mineralization                                                     1 (17%)                                            
      Cornea, Fibrosis                                 1 (50%)      1 (11%)                   1 (33%)                               
      Cornea, Inflammation, Chronic                                 1 (11%)                                                         
      Posterior Chamber, Inflammation, Chronic                                                1 (33%)                               
      Retina, Degeneration                             1 (50%)                                1 (33%)                               
      Sclera, Metaplasia, Osseous                                   1 (11%)                                                         
   Harderian Gland                                    (1)                       (1)          (1)                                    
      Hyperplasia                                      1 (100%)                                                                     
      Inflammation, Chronic                                                                   1 (100%)                              
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (50)         (50)         (50)         (50)                                   
      Autolysis                                                     2 (4%)                                                          
      Congestion                                       2 (4%)                                 2 (4%)                                
      Cyst                                             2 (4%)       6 (12%)      1 (2%)       7 (14%)                               
      Hemorrhage                                                    1 (2%)       1 (2%)                                             
      Hydronephrosis                                                1 (2%)       1 (2%)                                             
      Nephropathy                                     48 (96%)     50 (100%)    50 (100%)    49 (98%)                               
      Artery, Inflammation, Chronic Active,                                                                                         
          Necrotizing                                               1 (2%)                                                          
      Collecting Tubule, Mineralization                                          1 (2%)                                             
      Interstitial Tissue, Inflammation, Acute                                                1 (2%)                                
      Interstitial Tissue, Proximal Convoluted                                                                                      
          Renal Tubule, Inflammation, Acute                         1 (2%)                                                          
      Proximal Convoluted Renal Tubule,                                                                                             
          Mineralization                                            1 (2%)       2 (4%)       5 (10%)                               
      Proximal Convoluted Renal Tubule, Necrosis                    1 (2%)                    1 (2%)                                
      Proximal Convoluted Renal Tubule, Epithelium,                                                                                 
           Pigmentation                                5 (10%)      2 (4%)       3 (6%)                                             
      Renal Tubule, Hyperplasia                        1 (2%)       1 (2%)       2 (4%)       4 (8%)                                
      Renal Tubule, Hyperplasia, Cystic                             1 (2%)       1 (2%)                                             
      Transitional Epithelium, Hyperplasia            14 (28%)      9 (18%)     16 (32%)     27 (54%)                               
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   17                                                              
NTP Experiment-Test: 05033-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                             QUERCETIN                                         Date: 09/04/94  
Route: DOSED FEED                                                                                                 Time: 20:31:54  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     CONTROL      0.1% LM      1.0% MM      4.0% HM                                   
                                                   UM                                                                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
URINARY SYSTEM - CONT                                                                                                               
      Transitional Epithelium, Mineralization          1 (2%)                                                                       
   Urethra                                                                                   (1)                                    
      Calculus Micro Observation Only                                                         1 (100%)                              
   Urinary Bladder                                    (50)         (49)         (49)         (48)                                   
      Calculus Micro Observation Only                  2 (4%)                                 1 (2%)                                
      Inflammation, Chronic                                         2 (4%)       1 (2%)                                             
      Artery, Mineralization                                                     1 (2%)                                             
      Serosa, Mineralization                                                                  1 (2%)                                
      Submucosa, Hemorrhage                                         1 (2%)                                                          
      Subserosa, Mineralization                                     1 (2%)       1 (2%)                                             
      Transitional Epithelium, Hyperplasia                                       1 (2%)                                             
      Wall, Mucosa, Muscularis, Inflammation,                                                                                       
          Acute, Diffuse, Necrotizing                                                         1 (2%)                                
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   18                                                              
                             ------------------------------------------------------------                                           
                             ----------              END OF REPORT             ----------                                           
                             ------------------------------------------------------------